Protxx

What Protxx does

Protxx Inc. is a privately held healthcare technology company founded in 2016 and headquartered in Menlo Park, California, with additional operations in Calgary, Canada, and a clinical office in Sacramento. The company develops wearable sensor technology combined with machine learning to detect, quantify, and monitor complex neurophysiological impairments including concussions, stroke, multiple sclerosis, and Parkinson's disease. Its commercial platform, the PROTXX Clinic Platform-as-a-Service, integrates a proprietary physiological vibration acceleration (Phybrata) sensor that captures microscopic involuntary body motions, a mobile application for test configuration, and cloud-based data analytics and reporting; the products are not FDA-approved medical devices according to the company's own disclosures.

The technical foundation rests on a proprietary machine learning engine that derives digital biomarkers from phybrata signals and classifies impairments by their unique biomechanical vibrational signatures. The platform is positioned to deliver a one-minute, non-invasive assessment intended to replace multiple time-consuming specialist evaluations, with capabilities for both in-clinic use and remote patient monitoring that includes gait analysis. Protxx holds 21 patent applications covering its sensor, ML, and methods technology and has published peer-reviewed research validating a growing library of phybrata digital biomarkers. The company also offers synthetic phybrata data sets for research and biomarker development.

Protxx monetizes through a combination of hardware sales (Phybrata sensors and charging cases), subscription licensing of the PROTXX Clinic Platform to healthcare delivery organizations and research institutions, and professional services tied to R&D and clinical pilot collaborations. Pricing is quote-based with annual billing. Distribution is executed via direct enterprise B2B sales supplemented by channel partnerships, including a global distribution agreement with LOK Corporation and a regional clinical channel relationship with Jali Medical that showcases the platform at neuroscience conferences. The publicly identified leadership team consists of five members, including a repeat founder/operator CEO.

Name

Protxx

Legal name

PROTXX Inc.

Website

https://protxx.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Protxx develops wearable phybrata sensors and proprietary machine learning software to detect and quantify neurophysiological impairments such as concussions, stroke, MS, and Parkinson's disease, serving clinical neurology, rehabilitation, and sports medicine providers through its PROTXX Clinic Platform-as-a-Service.

Ownership category

akta.pro rank

Product category

Digital Health Diagnostics Platform

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)

akta.pro industry

PRIMARYHLAHACAE

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYHLALAFAJ

Neurology RPM (epilepsy, Parkinson’s, MS monitoring)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

SECONDARYHLALAGAC

Neurology Telemedicine Platforms

Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

SECONDARYHLACAPAI

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHDAAALAL

Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial)

Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools

Keywords

• Wearable health sensors
• Neurophysiological diagnostics
• Remote patient monitoring
• Machine learning healthcare
• Clinical assessment platform

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations, Infrastructure

Revenue model

1. PROTXX Clinic Platform License: Platform-as-a-Service (PaaS) solution licensed to healthcare delivery and research teams. Subscription-based licensing model for clinical use.
2. Phybrata Sensors and Hardware: Sale of phybrata sensors and charging case hardware components.
3. R&D and Clinical Pilot Collaborations: Research partnerships and laboratory/clinical pilot opportunities with next-generation solutions, potentially including service fees.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Protxx develops the Phybrata wearable physiological vibration acceleration sensor combined with a proprietary machine learning engine and cloud-based Platform-as-a-Service (PaaS) for rapid quantitative neurophysiological assessments. The integrated platform—sensor, mobile app, and cloud analytics—delivers one-minute non-invasive tests for concussions, stroke, multiple sclerosis, Parkinson's disease, and other conditions in clinical offices or via remote patient care.

Product overview

PROTXX offers the PROTXX Clinic Platform-as-a-Service (PaaS), a unified product combining four integrated components: the Phybrata sensor (wearable device detecting microscopic body motions), the Clinic Mobile App (for rapid test configuration and data collection), Cloud-Based Data Analytics (signal processing, ML analysis, and reporting), and the PROTXX Machine Learning Engine (deriving digital biomarkers for neurophysiological impairment classification). The platform supports clinical neurology, rehabilitation medicine, and sports medicine applications.

Differentiator

Problem solved

Functional benefit

Brands

• PROTXX Clinic: Platform-as-a-Service solution integrating phybrata sensors, mobile app, and cloud-based data analytics for clinical neurological assessments
• Phybrata
• PROTXX Clinic RPM

Products and services

• Phybrata Sensor Wearable physiological vibration acceleration sensor that detects microscopic involuntary motions of the body, both normal and pathological. Attaches with a disposable adhesive for use in clinical or remote settings. Used by healthcare professionals and researchers to measure physiological metrics for neurophysiological assessment.
• Clinic Mobile App Mobile application that allows clinicians and users to configure tests and collect phybrata sensor data in less than a minute, presenting results instantly via simple and intuitive reports. Used by healthcare professionals in clinical and remote patient care settings.
• Cloud-Based Data Analytics Cloud-based data services providing signal processing, data analysis, machine learning, and reporting for monitoring patient progress over time and enabling real-time treatment adjustments. Used by healthcare delivery organizations and clinical research teams to support personalized neurophysiological care.
• PROTXX Clinic Platform Platform-as-a-Service (PaaS) solution integrating the phybrata sensor, mobile app, and cloud-based data analytics to enable easy-to-use neurophysiological testing in any doctor's office or via remote patient care. Licensed to healthcare delivery organizations, clinical research teams, rehabilitation medicine, and sports medicine practitioners for rapid quantitative assessment of concussions, stroke, multiple sclerosis, Parkinson's disease, and other neurophysiological conditions.
• PROTXX Remote Neurophysiological Patient Management Platform Remote patient management platform that integrates phybrata sensors, mobile app, and cloud-based analytics for in-clinic and remote care of neurophysiological conditions. Enables at-home neuromotor testing and continuous patient monitoring for healthcare providers managing concussion, stroke, MS, Parkinson's, and similar patients.

Quantifiable outcome

• One-minute test results vs. multiple time-consuming specialist tests
• +1 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Jali MedicalcoreChannel Partner/ Reseller/ Distributor · 10 November 2023Jali Medical serves as distribution partner showcasing PROTXX Clinic Platform at neuroscience conferences (Neuroscience 2022, 2023, IEPRS Annual Conference 2023, 4th International Brain Stimulation Conference).
• Canadian Sport Institute CalgarycoreStrategic or Co-development Partner · 5 October 2023Partnership to enhance athlete concussion management. Canadian Sport Institute Calgary supports elite athlete health and performance, using PROTXX technology for concussion assessment and management.
• Vivo Cura HealthminorStrategic or Co-development Partner · 23 July 2022Collaboration to study minimally invasive pain interventions. Research partnership exploring applications of phybrata sensing technology in pain management.
• University of VictoriaminorStrategic or Co-development Partner · 16 December 2021Collaboration to investigate phybrata biomarkers for Multiple Sclerosis. Academic research partnership for biomarker development in MS assessment.
• AltaMLcoreTechnology or Integration · 25 November 2021Partnership combining phybrata sensors and machine learning to set new benchmark in concussion diagnostics. Co-development of ML algorithms for improved diagnostic accuracy.
• University of AlbertacoreStrategic or Co-development Partner · 28 September 2021Partnership with University of Alberta to expand phybrata sensing to gait analysis and activities of daily living. Remote personalized healthcare collaboration for MS patients. Initial collaboration announced June 2020.
• Alberta Healthcare and Machine Learning Innovation EcosystemscoreStrategic or Co-development Partner · 12 May 2021PROTXX launches collaboration with Alberta healthcare and machine learning innovation ecosystems. January 2020 announcement of Alberta collaborations with healthcare and ML innovation partners.
• LOK CorporationcoreChannel Partner/ Reseller/ Distributor · 2 October 2020Global distribution partnership announced October 2020 for worldwide distribution of PROTXX products. LOK Corporation serves as a key global channel partner for market expansion.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Empatica: Empatica develops FDA-cleared wearable sensors and digital biomarkers for neurological conditions including epilepsy, migraine, and autism. Highly comparable as a wearable + ML platform targeting neurology clinical use cases and remote patient monitoring.
• Ceribell: Ceribell makes a point-of-care EEG system and AI-based seizure detection for hospital neurology. Comparable as a clinical neurology monitoring platform combining novel hardware sensors with proprietary algorithms to support neurological diagnosis and monitoring.
• Rune Labs: Rune Labs uses wearable sensors, ML, and digital biomarkers to support Parkinson's disease and MS care, including FDA-cleared software for PD. Directly comparable as a wearable + digital biomarker platform in neurology with remote monitoring and clinical-decision support.
• ActiGraph: ActiGraph manufactures clinical-grade wearable activity and sleep monitors used in pharmaceutical trials and academic research. Comparable as a hardware-plus-cloud wearable platform serving clinical research, neurology, and rehabilitation end markets.
• Emotiv: Emotiv builds EEG-based wearable headsets and cloud analytics for neuroscience research, brain-computer interfaces, and consumer wellness. Comparable as a wearable neurophysiological sensor company combining proprietary hardware with ML/analytics software.
• BioStamp (formerly MC10): BioStamp develops conformal wearable biosensors that capture high-fidelity physiological motion and biomarker data for clinical research. Comparable as a wearable physiological sensor company targeting neurology, sports, and clinical research use cases.

Emerging players

• Kernel: Kernel develops non-invasive brain measurement hardware (e.g., Kernel Flow) using TD-fNIRS, with cloud analytics for cognition and neurological monitoring. Comparable as a novel wearable neurophysiological sensor + analytics platform pursuing research and clinical markets.
• Neursantys: Neursantys is an early-stage neurotechnology company that integrated Protxx's Phybrata sensor into its wearable neuroprosthetic device. A disclosed Protxx partner, making it a relevant emerging peer with overlapping technology and customer ecosystems.
• Brainbox: Brainbox is an early-stage neuroscience product company with a neuroscience product partnership with Protxx (announced June 2021). Comparable as an emerging neuroscience wearable/diagnostics peer operating in adjacent neurology markets.

Broad incumbents

• iRhythm Technologies: iRhythm is a public digital healthcare company whose Zio long-term cardiac monitoring patch combines a wearable biosensor with a cloud analytics/ML platform. A broader incumbent demonstrating the wearable + AI + clinician-report commercial model that Protxx is pursuing in neurology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Protxx